Why Deep Yellow, Meteoric Resources, Novonix, and ResMed shares are storming higher

What is getting investors excited about these shares today?

| More on:
A women cheers with clenched fists having read some good news on her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street's lead and dropped into the red. At the time of writing, the benchmark index is down 0.3% to 7,016.4 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

Deep Yellow Limited (ASX: DYL)

The Deep Yellow share price is up over 2% to $1.31. Investors have been buying this uranium share today after Bell Potter released a bullish note. Its analysts have retained their speculative buy rating and increased their price target by 74% to $1.84. It said: "[W]e see DYL in pole position to capitalise on the momentum and advance its two flagship projects into production within the next 3-4 years."

Meteoric Resources NL (ASX: MEI)

The Meteoric Resources share price is up 7% to 25.2 cents. This morning, this rare earths explorer announced very positive results from metallurgy testworks from its operation in Brazil. Management notes that the testwork from diamond drill cores collected during a metallurgical sampling program is believed to include the highest rare earth leach extractions ever reported for a standard ammonium sulphate (AMSUL) wash at pH 4.0 for any listed company on the ASX or globally.

Novonix Ltd (ASX: NVX)

The Novonix share price is up 4.5% to 83.5 cents. This follows news that the battery materials and technology company will receive up to C$3 million in research and development funding and advisory services from the National Research Council of Canada Industrial Research Assistance Program. Novonix plans to use the funds to advance two important research and development initiatives.

ResMed Inc (ASX: RMD)

The ResMed share price is up almost 5% to $22.97. A number of brokers have been urging investors to buy this sleep treatment company's shares this month following a significant decline. Yesterday, Goldman Sachs said that its analysts "see strong asymmetric upside risk from current levels."

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »